Akari Therapeutics Plc Stock Market Value
| AKTX Stock | USD 1.35 0.02 1.50% |
| Symbol | Akari |
Akari Therapeutics PLC Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akari Therapeutics. If investors know Akari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akari Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Akari Therapeutics PLC is measured differently than its book value, which is the value of Akari that is recorded on the company's balance sheet. Investors also form their own opinion of Akari Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akari Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akari Therapeutics' market value can be influenced by many factors that don't directly affect Akari Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akari Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akari Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akari Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Akari Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Akari Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Akari Therapeutics.
| 09/03/2024 |
| 01/31/2025 |
If you would invest 0.00 in Akari Therapeutics on September 3, 2024 and sell it all today you would earn a total of 0.00 from holding Akari Therapeutics PLC or generate 0.0% return on investment in Akari Therapeutics over 150 days. Akari Therapeutics is related to or competes with Armata Pharmaceuticals, Anebulo Pharmaceuticals, Processa Pharmaceuticals, Salarius Pharmaceuticals, Pulmatrix, Capricor Therapeutics, and Soleno Therapeutics. Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoim... More
Akari Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Akari Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Akari Therapeutics PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 47.27 | |||
| Value At Risk | (14.53) | |||
| Potential Upside | 11.21 |
Akari Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Akari Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Akari Therapeutics' standard deviation. In reality, there are many statistical measures that can use Akari Therapeutics historical prices to predict the future Akari Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (1.32) | |||
| Treynor Ratio | 1.65 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akari Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Akari Therapeutics PLC Backtested Returns
Akari Therapeutics PLC secures Sharpe Ratio (or Efficiency) of -0.0808, which signifies that the company had a -0.0808 % return per unit of standard deviation over the last 3 months. Akari Therapeutics PLC exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Akari Therapeutics' mean deviation of 5.47, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Akari Therapeutics are expected to decrease at a much lower rate. During the bear market, Akari Therapeutics is likely to outperform the market. At this point, Akari Therapeutics PLC has a negative expected return of -0.65%. Please make sure to confirm Akari Therapeutics' jensen alpha, as well as the relationship between the kurtosis and price action indicator , to decide if Akari Therapeutics PLC performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.09 |
Virtually no predictability
Akari Therapeutics PLC has virtually no predictability. Overlapping area represents the amount of predictability between Akari Therapeutics time series from 3rd of September 2024 to 17th of November 2024 and 17th of November 2024 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Akari Therapeutics PLC price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Akari Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Akari Therapeutics PLC lagged returns against current returns
Autocorrelation, which is Akari Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Akari Therapeutics' stock expected returns. We can calculate the autocorrelation of Akari Therapeutics returns to help us make a trade decision. For example, suppose you find that Akari Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Akari Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Akari Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Akari Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Akari Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Akari Therapeutics Lagged Returns
When evaluating Akari Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Akari Therapeutics stock have on its future price. Akari Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Akari Therapeutics autocorrelation shows the relationship between Akari Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Akari Therapeutics PLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.